Dietary Carrageenan Amplifies the Inflammatory Profile, but not Permeability, of Intestinal Epithelial Cells from Patients With Crohn’s Disease

Eva Vissers(KU Leuven), João Sabino(KU Leuven), Marc Ferrante(Universitair Ziekenhuis Leuven), Kaline Arnauts(Rega Institute for Medical Research), Lorenzo Giorio(KU Leuven), Bram Verstockt(Universitair Ziekenhuis Leuven), Ward Zadora(KU Leuven), Christophe Matthys(Ghent University Hospital), Judith Wellens(KU Leuven), Séverine Vermeire(KU Leuven)
Inflammatory Bowel Diseases
December 24, 2024
10.1093/ibd/izae306
Cited by 11

Related Papers

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k
A decrease of the butyrate-producing species <i>Roseburia hominis</i> and <i>Faecalibacterium prausnitzii</i> defines dysbiosis in patients with ulcerative colitis
|Gut|2013|1.9k
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
|Journal of Crohn s and Colitis|2018|1.8k
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
|New England Journal of Medicine|2016|1.8k
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
|Journal of Crohn s and Colitis|2019|1.4k